Development of mobile technologies for the prevention of cervical cancer in Santiago, Chile study protocol: a randomized controlled trial

BACKGROUND: In Chile, more than 500 women die every year from cervical cancer, and a majority of Chilean women are not up-to-date with their Papanicolau (Pap) test. Mobile health has great potential in many health areas, particularly in health promotion and prevention. There are no randomized contro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Momany, McKenzie C., Martinez-Gutierrez, Javiera, Soto, Mauricio, Capurro, Daniel, Ciampi, Francis, Thompson, Beti, Puschel, Klaus
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5729241/
https://ncbi.nlm.nih.gov/pubmed/29237420
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3870-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados